| Old Articles: <Older 2861-2870 Newer> |
 |
The Motley Fool July 26, 2004 W.D. Crotty |
Boston Scientific on the Rebound The medical device maker posts robust earnings, softening the blow of the stent delivery system recall.  |
The Motley Fool July 26, 2004 Mark Mahorney |
StorageTek's Holding Pattern The data storage company anxiously awaits the great tech spending revival.  |
The Motley Fool July 26, 2004 Brian Gorman |
Stem Cell Researcher a Risk Geron could benefit from a new U.S. president, but in the end, studies of embryonic stem cells may or may not yield breakthroughs, so buying their stock now would be a gamble.  |
The Motley Fool July 26, 2004 David Meier |
Has Cummins Redlined? The diesel engine maker is a cyclical stock, so its strong results may mean it's running out of gas.  |
The Motley Fool July 26, 2004 Nathan Slaughter |
Landry's Looking Good The nation's second-largest seafood casual-dining chain sees record revenues and raises guidance. Landry's bottom line and stock price should both continue their upward climb.  |
The Motley Fool July 26, 2004 Phil Wohl |
Kellogg's Eye of the Tiger The leading cereal producer is benefiting from cost-cutting initiatives. The company's shares are attractive as a total return investment, given the company's tremendous brand name, management's cost initiatives, and the healthy 2.72% dividend yield.  |
The Motley Fool July 26, 2004 Ben McClure |
SBC Down, Not Out Is the telecom company really down for the count? DSL sales are offsetting local phone losses. Competition will continue to be fierce, prompting more price wars and putting loads of pressure on margins.  |
The Motley Fool July 26, 2004 Dave Marino-Nachison |
Maytag Needs Repairs Investors have stopped waiting for the appliance maker to come out of turnaround mode.  |
The Motley Fool July 26, 2004 Brian Gorman |
More Dough From California Pizza? The earnings were tasty for the specialty restaurant chain operator, but could rise even more in the coming quarters.  |
The Motley Fool July 26, 2004 Rich Smith |
Is DoubleClick a Green Gene Stock? The online advertiser may have potential despite last week's fall.  |
| <Older 2861-2870 Newer> Return to current articles. |